M. Butler
Molecular Biology · Nature Medicine · 2004–2018
A researcher in the Science corpus: 4 papers; trusts 9 researchers and is trusted by 7 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 55 citations into it; #5,716 of 17,773 by trust here, #7,041 by citations
- Pharmacology — 20 citations into it; #361 of 1,112 by trust here, #688 by citations
- Biotechnology — 8 citations into it
- Computational Theory and Mathematics — 8 citations into it; #7,551 of 12,182 by trust here, #6,165 by citations
- Oncology — 8 citations into it
- Surgery — 8 citations into it
- Organic Chemistry — 7 citations into it
Whom M. Butler trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- D. Newman
- C. Walsh
- Yves Pommier
- A. Fürstner
- G. Shapiro
- Amy C. Anderson
- R. Duncan
- J. Tobert
- Joseph A. Baur
- G. Cragg
Who trusts M. Butler overall
Papers from M. Butler's perspective
Ordered by how strongly the researchers M. Butler trusts endorse each paper. Same corpus, a different order for every researcher.
- Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease (Nature)
- A small molecule inhibitior of the NLRP3 inflammasome is a potential therapeutic for inflammatory diseases (Nature Medicine)
- Lessons from natural molecules (Nature)
- A planning strategy for diversity-oriented synthesis. (Angewandte Chemie)
- A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis (Science)
- Natural products as sources of new drugs over the period 1981-2002. (Journal of Natural Products)
- Drugs for bad bugs: confronting the challenges of antibacterial discovery (Nature reviews. Drug discovery)
- Environmental Genome Shotgun Sequencing of the Sargasso Sea (Science)
- Linezolid resistance in a clinical isolate of Staphylococcus aureus. (The Lancet)
- Marine natural products and related compounds in clinical and advanced preclinical trials. (Journal of Natural Products)
Their papers
- A small molecule inhibitior of the NLRP3 inflammasome is a potential therapeutic for inflammatory diseases (2015) — 2,420 citations
- The role of natural product chemistry in drug discovery. (2004) — 1,400 citations
- Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice (2018) — 734 citations
- Natural products to drugs: natural product-derived compounds in clinical trials. (2005) — 972 citations